News Gilead strikes deal to expand HIV drug access in 120 countri... Gilead Sciences has taken a major step towards increasing global access to HIV prevention with the signing of royalty-free
News Revisionist history on healthcare at the VP debate In the VP debate, Tim Walz and JD Vance were forceful, unexpectedly convivial, and fast and loose with the facts, particularly on healthcare.
News Blue Shield of California bypasses PBMs to slash Humira pric... Blue Shield of California is pioneering a strategy that bypasses traditional pharmacy benefit managers to slash the price of Humira by up to 90%
News FDA issues summary of grants, promotes rare disease research The US Food and Drug Administration (FDA) has provided an ‘at-a-glance’ summary of the agency’s news.
News J&J's 340B rebate scheme stymied by strong-arm HRSA letter Johnson & Johnson's stand against 340B abuse and duplicate discounts came to a halt in the face of HRSA threats of termination.
R&D Treating the chronic diseases GLP-1s miss, with Laurent Auda... Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
